Results
2
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
2 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARGX | €604.60 | -0.2% | 79.5% | €36.5b | €596.31 | PS20x | E55.7% | n/a | Pharmaceuticals & Biotech | ||
UCB | €186.60 | 0.6% | 140.4% | €35.4b | €192.69 | PE147.5x | E33.0% | 0.7% | Pharmaceuticals & Biotech |